Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$114M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$31.3M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$26.4M |
| 4 |
Tyler Technologies
TYL
|
+$25M |
| 5 |
Brown & Brown
BRO
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$249M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Alibaba
BABA
|
+$140M |
| 5 |
Amazon
AMZN
|
+$99.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.49% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.19% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Acadia Realty Trust
AKR
$2.86B
| $4.19M | ﹤0.01% |
161,700
+5,900
| +4% | +$162K |
|
1277
NovaGold Resources
NG
$3.4B
| $4.19M | ﹤0.01% |
468,900
+6,700
| +1% | +$46.4K |
|
1278
John Wiley & Sons Class A
WLY
$2.63B
| $4.18M | ﹤0.01% |
86,100
+400
| +0.5% | +$18.6K |
|
1279
Quaker Houghton
KWR
$2.95B
| $4.16M | ﹤0.01% |
25,300
+200
| +0.8% | +$31K |
|
|
PRO
1280
DELISTED
PROS Holdings
PRO
| $4.15M | ﹤0.01% |
69,300
+5,200
| +8% | +$300K |
|
|
CMBT
1281
CMB.TECH NV
CMBT
$4.92B
| $4.15M | ﹤0.01% |
336,947
+9,430
| +3% | +$104K |
|
1282
Synaptics
SYNA
$4.2B
| $4.14M | ﹤0.01% |
63,000
-1,900
| -3% | -$100K |
|
1283
Asbury Automotive
ABG
$3.78B
| $4.14M | ﹤0.01% |
37,000
+500
| +1% | +$53.8K |
|
|
ECHO
1284
EchoStar
ECHO
$26.6B
| $4.12M | ﹤0.01% |
95,100
+4,900
| +5% | +$197K |
|
1285
Deluxe
DLX
$1.11B
| $4.1M | ﹤0.01% |
82,200
| – | – |
|
|
MIME
1286
DELISTED
Mimecast Limited
MIME
| $4.1M | ﹤0.01% |
94,500
+2,100
| +2% | +$87.3K |
|
1287
PennyMac Financial
PFSI
$4.13B
| $4.1M | ﹤0.01% |
120,400
+2,800
| +2% | +$90.9K |
|
|
MANT
1288
DELISTED
Mantech International Corp
MANT
| $4.1M | ﹤0.01% |
51,287
+1,100
| +2% | +$82.5K |
|
1289
Kinsale Capital Group
KNSL
$8.59B
| $4.08M | ﹤0.01% |
40,162
+2,200
| +6% | +$219K |
|
1290
Patterson-UTI
PTEN
$4.16B
| $4.07M | ﹤0.01% |
387,900
-3,400
| -0.9% | -$30.8K |
|
1291
Glaukos
GKOS
$11.2B
| $4.06M | ﹤0.01% |
74,600
+9,600
| +15% | +$584K |
|
1292
Terex
TEX
$7.57B
| $4.06M | ﹤0.01% |
136,300
+2,700
| +2% | +$75.9K |
|
|
GOOS
1293
Canada Goose Holdings
GOOS
$850M
| $4.05M | ﹤0.01% |
112,000
| – | – |
|
1294
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.44B
| $4.05M | ﹤0.01% |
125,734
+5,600
| +5% | +$166K |
|
1295
Trustmark
TRMK
$2.8B
| $4.04M | ﹤0.01% |
117,200
+1,500
| +1% | +$51.8K |
|
1296
Empire State Realty Trust
ESRT
$836M
| $4.04M | ﹤0.01% |
289,300
+7,700
| +3% | +$108K |
|
1297
Dorman Products
DORM
$3.95B
| $4.04M | ﹤0.01% |
53,300
+800
| +2% | +$60.5K |
|
|
ZGNX
1298
DELISTED
Zogenix, Inc.
ZGNX
| $4.03M | ﹤0.01% |
77,300
+1,400
| +2% | +$64.1K |
|
|
VRE
1299
DELISTED
Veris Residential
VRE
| $4.01M | ﹤0.01% |
173,300
+3,400
| +2% | +$73.7K |
|
|
WBT
1300
DELISTED
Welbilt, Inc.
WBT
| $4M | ﹤0.01% |
256,500
+5,100
| +2% | +$87.3K |
|
Similar funds
Swiss National Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Swiss National Bank held 2,602 positions worth $97.5B, up 3.6% from $94.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Swiss National Bank withdrew a net $3.98B in Q4 2019, closing 96 positions and reducing 725 holdings. Its most notable exit was Celgene Corp, an estimated $231M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Match Group worth $14.7M.
- Swiss National Bank's largest Q4 2019 buy was Match Group: 179,200 shares worth $14.7M.
- Swiss National Bank added most to Bristol-Myers Squibb in Q4 2019, an estimated $114M increase.
- Swiss National Bank's biggest Q4 2019 reduction was Apple, cutting an estimated $249M.
- Swiss National Bank fully exited Celgene Corp in Q4 2019, selling an estimated $231M.
- Swiss National Bank's ten largest holdings make up 19% of its $97.5B portfolio in Q4 2019.
- Swiss National Bank opened 82 new positions and closed 96 in Q4 2019.
- Swiss National Bank's portfolio value rose 3.6% quarter-over-quarter to $97.5B.
Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.